WoS
🏆 JCR Q2 · JIF 3,6
YÖKSİS Eşleşti
2026 Article 6. Yazar
Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2-Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey
BREAST CANCER-TARGETS AND THERAPY
·
Cilt 18
·
ISSN 1179-1314
Doç. Dr. HAMİT BAŞARAN
· 15 yazar
WoS
🏆 JCR Q1 · JIF 2,9
YÖKSİS Eşleşti
2026 Article 11. Yazar
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study
MEDICINA-LITHUANIA
·
Cilt 62
·
ISSN 1010-660X
Prof. Dr. ORHAN ÖNDER EREN
· 14 yazar
WoS
2020 Article 2. Yazar
The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
·
Cilt 26, s. 1611-1620
·
ISSN 1078-1552
Dr. Öğr. Üyesi SÜLEYMAN ŞAHİN
· 9 yazar
WoS
2020 Article 25. Yazar
Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey
JOURNAL OF BUON
·
Cilt 25, s. 1897-1903
·
ISSN 1107-0625
Dr. Öğr. Üyesi SÜLEYMAN ŞAHİN
· 29 yazar
WoS
🏆 JCR Q4 · JIF 0,2 2019 Article 1. Yazar
Treatment Outcomes of Metastatic Colorectal Cancer Patients Treated with Regorafenib as Third-Line Setting-A Multicenter Study
ISTANBUL MEDICAL JOURNAL
·
Cilt 20, s. 82-87
·
ISSN 2619-9793
Dr. Öğr. Üyesi SÜLEYMAN ŞAHİN
· 2 yazar